Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development

SummaryThe rapid emergence of resistance to novel tuberculosis drugs, such as bedaquiline, is a key threat to the long-term effectiveness of novel regimens. Given that the introduction of these agents has enabled the introduction of an all-oral regimen for rifampicin-resistant and multidrug-resistan...

Celý popis

Podrobná bibliografie

Vydáno v:	The Lancet infectious diseases
Hlavní autoři:	Saluzzo, Francesca, MD, Yerlikaya, Seda, PhD, Dorman, Susan Elizabeth, MD, Eisenach, Kathleen, PhD, Farhat, Maha Reda, MD, Ismail, Nazir, FCPath, Lienhardt, Christian, PhD, Walker, Timothy M, Prof, Jones, Fatima, PhD, Yepes, Ana, PhD, Penn-Nicholson, Adam, PhD, Ruhwald, Morten, MD, Kana, Bavesh, PhD, Denkinger, Claudia Maria, MD, Cirillo, Daniela Maria, MD
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	2025
Témata:	Infectious Disease
ISSN:	1473-3099
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!